Últimos Artículos de Endocrine Related Cancer
- GH-dependent growth of experimentally induced carcinomas in vivo
- Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors
- Aggressive versus indolent insulinomas: new clinicopathological insights
- Diagnosis and management of parathyroid carcinoma: a state-of-the-art review
- Inflammation-based scores as predictors of treatment response in advanced adrenocortical carcinoma
- Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer
- The science behind the relations among cancer, height, growth patterns, and growth hormone axis
- Update on the genetics of paragangliomas
- Prognostic value of the Weiss and Wieneke (AFIP) scoring systems in pediatric ACC – a mini review
- Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine
- A study of acromegaly-associated headache with somatostatin analgesia
- Cell diversity and immune infiltration in the parathyroid tumour microenvironment
- Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
- Percutaneous ablation of low-risk papillary thyroid cancer
- Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer
- Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouse
- Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation
- Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma
- SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
- Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models